A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer...

Area of Science:

• Biochemistry
• Cardiovascular Biology
• Genetics

Background:

• The apolipoprotein A-I(Milano) (A-I(M)) variant is associated with low plasma HDL levels but not premature coronary heart disease (CHD).
• Understanding the mechanisms behind cholesterol metabolism in A-I(M) carriers is crucial for cardiovascular health research.

Purpose of the Study:

• To investigate the ability of sera from A-I(M) carriers to promote cholesterol efflux through the ABCA1 pathway.
• To identify the specific HDL components responsible for enhanced cholesterol efflux in A-I(M) carriers.

Main Methods:

• Comparison of cholesterol efflux from macrophages and fibroblasts using sera from A-I(M) carriers and matched controls.
• Analysis of HDL particle composition in A-I(M) sera.
• Assessment of the effect of chymase treatment on cholesterol efflux.

Main Results:

• Sera from A-I(M) carriers showed significantly greater ABCA1-driven cholesterol efflux compared to control sera in both macrophages and fibroblasts.
• A-I(M) sera contain normal prebeta-HDL and a unique, small HDL particle with the A-I(M) dimer.
• Chymase treatment degraded these HDL particles and abolished ABCA1-mediated efflux, with serum HDL content strongly correlating with efflux capacity.

Conclusions:

• The enhanced ABCA1-mediated cholesterol efflux in A-I(M) carriers is attributed to the combined presence of normal prebeta-HDL and unique, protease-sensitive HDL particles containing the A-I(M) dimer.
• These findings elucidate a novel mechanism for cholesterol removal in individuals with the A-I(M) variant, potentially explaining their lack of premature CHD.
• The study highlights the functional significance of specific HDL particles in cholesterol homeostasis and cardiovascular protection.